Genentech · 20 hours ago
2026 Summer Intern - Discovery Oncology Department
South San Francisco, CA
Internship
Onsite
Intern
$46/hr - $46/hr
Start in 2026 SummerGenentech is a leading biotechnology company seeking a highly talented and motivated intern for their Discovery Oncology Department. The intern will investigate cellular stress mechanisms in cancer-relevant model systems and contribute to research efforts using molecular and biochemical techniques.
BiotechnologyLife ScienceManufacturing
Responsibilities
Work in a collaborative environment with other scientists in the group to design and execute experiments
Keep detailed records of the research findings using an electronic notebook
Communicate and present results to a diverse group of scientists during internal meetings
Qualification
Required
Must be pursuing a PhD (enrolled student)
Molecular Biology, Cell Biology, Cancer Biology, Biochemistry, or related field
Hands-on research experience in a biology lab environment with prior experience in mammalian cell culture
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Able to work independently and collaboratively in a research environment
Experience in basic molecular, cellular, and biochemical techniques including immunoblotting and immunoprecipitation
Experience in chromatin biology and sequencing-based techniques such as RNA/ATAC/ChIP-seq is a plus
Benefits
Paid holiday time off benefits
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
Founded in 1976
10001+ employees
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Leadership Team
Ashley Magargee
Chief Executive Officer
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
Recent News
2026-01-23
Genetic Engineering News
2026-01-23
Company data provided by crunchbase